Membership News

BIVDA now has over 200 members from the IVD industry and can confidently liaise with stakeholders as the voice of the industry. We are in a unique position in being the representative Association for around 95% of IVD companies operating in the UK. The structure of our membership spans across spin outs and start-ups, through to multi-nationals across all disciplines,…

This week, the Secretary of State for Health and Social Care Sajid Javid set out the Government’s plan to tackle the elective care backlog. Included in the plan were several points which will most definitely be of interest to those in the diagnostics sector. In his speech in Parliament, Mr Javid began the section on diagnostics by heralding their importance,…

There have been a number of approvals which are set to be released imminently, so members should review the approved list which can be found at CTDA - approved-products Over the Christmas period, most suppliers have provided the outstanding requested information and those are still in the evaluation stages. There are approximately a dozen suppliers that have been rejected, but…

On the 25 January 2022, the National Covid-Testing Cell wrote to Pathology Incident Managers and laboratories across England informing them that funding was to be made available for Trusts using point of care devices. The funding is to fund interface software to middleware and/or middleware itself to aide connectivity to electronic patient record. Trusts are required to complete a business…

On 6 January 2022, the Government made new legislation approved by Parliament, which amended the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 (“the 2014 Regulations”). The document states that rules “will also apply where a regulated activity is delivered through agency workers, volunteers, locums, students or trainees, or contracted to another provider. Compliance will be monitored and…

We will now be taking part in Focus Groups hosted by MHRA, contributing to the group for Trade Associations and industry. This will span both medical devices and IVDs. Our contributions to this group will align with the submission from BIVDA for the UKCA consultation which closed in November, but below is a list of the topics which we have…

Gallagher Life Sciences Practice are currently running a Cyber Insurance and Risk Management marketing campaign to update and educate companies in the Life Science industry regarding the fast-evolving nature of cyber threats. The culmination of this campaign is a free webinar run by their Cyber Risk Management professionals, who will discuss the different tactics employed by cyber criminals, report on…